Tags: APFN | ML | Israel | Teva

Teva Chief Reports 'strong Progress' in Restructuring Plan

Thursday, 08 February 2018 10:38 AM

JERUSALEM (AP) — The chief executive of Teva Pharmaceuticals says he is making "strong progress" on the company's restructuring plan, but has acknowledged the generic drug giant faces a challenging 2018.

Kare Schultz, Teva's new CEO, provided the update as the company released its fourth-quarter earnings Thursday.

Teva in December announced plans to cut 14,000 jobs, roughly one-quarter of its work force, in a broad restructuring as it confronts lower prices for generics, the expiration of patents on its core Copaxone drug and a more than $30 billion debt load.

Speaking to analysts, Schultz said roughly half the layoffs should be complete by July, with the remainder taking place by the end of 2019. "Everything is on plan. Everything is on target," he said.

Teva forecast lower revenue for 2018.

© Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
GlobalTalk
The chief executive of Teva Pharmaceuticals says he is making "strong progress" on the company's restructuring plan, but has acknowledged the generic drug giant faces a challenging 2018.Kare Schultz, Teva's new CEO, provided the update as the company released its...
APFN,ML,Israel,Teva
129
2018-38-08
Thursday, 08 February 2018 10:38 AM
Newsmax Media, Inc.
 
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved